<DOC>
	<DOCNO>NCT02191657</DOCNO>
	<brief_summary>The purpose study examine safety , efficacy , pharmacokinetics different dosage deferiprone subject without HIV infection .</brief_summary>
	<brief_title>Antiretroviral Activity Pharmacokinetics Deferiprone Healthy Volunteers Asymptomatic HIV-infected Subjects</brief_title>
	<detailed_description>Three cohort enrol : two individual asymptomatically infect HIV one healthy volunteer . Dosages follow : - Cohort 1 ( asymptomatic HIV infected subject ) : 33 mg/kg deferiprone three time daily total 99 mg/kg/day - Cohort 2 ( healthy volunteer ) : 50 mg/kg deferiprone three time daily total 150 mg/kg/day - Cohort 3 ( asymptomatic HIV infected subject ) : 50 mg/kg deferiprone three time daily total 150 mg/kg/day</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Deferiprone</mesh_term>
	<criteria>Male female age ≥18 year ≤ 60 year . Absolute neutrophil count ( ANC ) &gt; 1000/mm3 African black population ≥ 1600/mm3 race . For Cohort 2 : HIVnegative For Cohorts 1 3 : HIV1 positive ; CD4 count least 300/mm3 ; HIV1 RNA copy ( viral load ) &gt; 10 000 copies/mL serum ; current physical health stable require antiretroviral treatment For Cohorts 1 3 : Chest xray show absence active infectious disease ( tuberculosis , viral atypical bacteria parasitic infection ) . Presence severe concomitant disease . History current , recurrent recent ( 4 week ) febrile disease . History opportunistic infection , neoplasm AIDSdefining condition . Inability discontinue medication screening onwards , least 2 week first admission ; particular antiviral therapy immunosuppressive activity . Significant liver impairment : aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) ≥ 2.5 time upper normal limit . Significant kidney impairment : serum creatinine ≥ two time upper normal limit . Any concomitant disorder resultant therapy likely interfere subject compliance study procedure . Known hypersensitivity test material related compound . Positive test Hepatitis B and/or C antibody . A history multiple and/or severe allergy drug food history anaphylactic reaction . History seizures epilepsy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>HIV</keyword>
	<keyword>deferiprone</keyword>
	<keyword>iron chelation</keyword>
</DOC>